RPAM
MEDP icon

Rhenman & Partners Asset Management’s Medpace MEDP Stock Holding History

Rhenman & Partners Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,800
Closed -$1.16M – 102
2025
Q1 		$1.16M Sell
3,800
-3,000
-44% -$1.01M 0.13% 86
2024
Q4 		$2.26M Sell
6,800
-700
-9% -$237K 0.23% 78
2024
Q3 		$2.5M Buy
7,500
+5,000
+200% +$1.9M 0.2% 85
2024
Q2 		$1.03M Buy
+2,500
New +$990K 0.1% 89

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Rhenman & Partners Asset Management's MEDP Position: Q2 2025 in Review

Rhenman & Partners Asset Management sold out of Medpace (MEDP) in Q2 2025, closing a stake of 3,800 shares — an estimated $1.16M sold.

Rhenman & Partners Asset Management first reported a position in MEDP in Q2 2024 and held it in 4 quarters. The position peaked at $2.5M in Q3 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • Rhenman & Partners Asset Management reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 3,800 Medpace shares in Q2 2025, an estimated $1.16M.
  • Rhenman & Partners Asset Management first reported a position in Medpace in Q2 2024 and held it in 4 quarters.
  • Rhenman & Partners Asset Management's Medpace position peaked at $2.5M in Q3 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.